Pillstats
Rx only · Injection, Solution · Intramuscular

Bumetanide

Bumetanide

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03CA02
RxCUI (US)1808
US makers2 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

41821231642025 Q12025 Q22025 Q32025 Q42026 Q1
108
Rx · 2026 Q1
839
Units dispensed
+209%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Anthea Pharma Private Limitedunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 31, 2018
    SHORTAGEDrug shortage: Bumetanide Injection (Sagent Pharmaceuticals)

    Bumetanide Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Cardiovascular.